Efficacy of MCI-186, a free-radical scavenger and antioxidant, for resuscitation of nonbeating donor hearts

Journal of Thoracic and Cardiovascular Surgery

Volumn 133, Issue 6, 2007, Pages 1626-1632

  Kotani, Yasuhiro ^a   Ishino, Kozo ^a   Osaki, Satoru ^a   Honjo, Osami ^a   Suezawa, Takanori ^a   Kanki, Kazushige ^a   Yutani, Chikao ^b   Sano, Shunji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NORPHENAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY SINUS; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HEART ARREST; HEART OUTPUT; HEART TRANSPLANTATION; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; SWINE; SYSTOLIC BLOOD PRESSURE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; ANTIPYRINE; CARDIOPULMONARY RESUSCITATION; FREE RADICAL SCAVENGERS; HEART FUNCTION TESTS; HEART TRANSPLANTATION; LIPID PEROXIDATION; STATISTICS, NONPARAMETRIC; SWINE;

EID: 34249099114     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.01.068     Document Type: Article

References (29)

1. Shirakura R., Matsuda H., Nakano S., Nakata S., Kaneko M., Miyamoto Y., et al. Cardiac function and myocardial performance of 24-hour-preserved asphyxiated canine hearts. Ann Thorac Surg 53 (1992) 440-444
2. Gundry S.R., Fukushima N., Eke C.C., Hill A.C., Zuppan C., and Bailey L.L. Successful survival of primates receiving transplantation with "dead," nonbeating donor hearts. J Thorac Cardiovasc Surg 109 (1995) 1097-1102
3. Wuerflein R., and Shumway N. Resuscitation and function of the cadaver heart. Circulation 35 4 Suppl (1966) I92-I95
4. Tam W., Robicsek F., and Daugherty H.K. The autoperfusing heart-lung preparation: a vehicle for the preservation of the resuscitated cadaver heart. J Thorac Cardiovasc Surg 58 (1969) 879-885
5. Hearse D.J., Humphrey S.M., and Chain E.B. Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol 5 (1973) 395-407
6. Osaki S., Ishino K., Kotani Y., Honjo O., Suezawa T., Kanki K., et al. Resuscitation of non-beating donor hearts using continuous myocardial perfusion: the importance of controlled initial reperfusion. Ann Thorac Surg 81 (2006) 2167-2171
7. McCord J.M. Oxygen-derived free radicals in postischemic injury. N Engl J Med 312 (1985) 159-163
8. Meerson F.Z., Kagan V.E., Kozlov Y.P., Belkina L.M., and Arkkhipenko Y.V. The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart. Basic Res Cardiol 77 (1982) 465-485
9. Mizuno A., Uemura K., and Nakashima M. Inhibitory effect of MCI-186, a free radical scavenger, on cerebral ischemia following rat middle cerebral artery occlusion. Gen Pharmacol 30 (1998) 575-578
10. Watanabe T., Yuki S., Egawa M., and Nishi H. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 268 (1994) 1597-1604
11. Yagi H., Horinaka S., and Matsuoka H. Edaravone prevented deteriorated cardiac function after myocardial ischemia-reperfusion via inhibiting lipid peroxidation in rat. J Cardiovasc Pharmacol 46 (2005) 46-51
12. Yoneda Y., Uehara T., Yamasaki H., Kita Y., Tabuchi M., and Mori E. Hospital-based study of the care and cost of acute ischemic stroke in Japan. Stroke 34 (2003) 718-724
13. Yanagisawa A., Miyagawa M., Ishikawa K., and Murota S. Cardioprotective effect of MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one) during acute ischemia-reperfusion injury in rats. Int J Angiol 3 (1994) 12-15
14. Takamatsu Y., Yuki S., and Watanabe T. [Studies on the concentrations of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186) in MCA occlusion and reperfusion model of rats.]. Jpn Pharmacol Ther 25 Suppl (1997) S1785-S1791 Japanese
15. Martin J., Lutter G., Ihling C., Siepe M., Wagner S., Hilberath J., et al. Myocardial viability twenty-four hours after orthotopic heart transplantation from non-heart beating donors. J Thorac Cardiovasc Surg 125 (2003) 1217-1228
16. Lundsgaard-Hansen P., Schilt W., Heitmann L., Oroz M., Buchler A., and Lemeunier A. Influence of the agonal period on the postmortem metabolic state of the heart. A problem in cardiac preservation. Ann Surg 174 (1971) 744-754
17. Casavilla A., Ramirez C., Shapiro R., Nghiem D., Miracle K., Bronsther O., et al. Experience with liver and kidney allografts from non-heart beating donors. Transplantation 59 (1995) 197-203
18. Kootsta G., Daemen J.H., and Oomen A.P. Categories of non-heart beating donors. Transplant Proc 27 (1995) 2893-2894
19. Watanabe T., Morita I., Nishi H., and Murota S. Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostaglandins Leukot Essent Fatty Acids 33 (1988) 81-87
20. Watanabe T., and Egawa M. Effects of an antistroke agent MCI-186 on cerebral arachidonate cascade. J Pharmacol Exp Ther 271 (1994) 1624-1629
21. Di Pierro D., Tavazzi B., Lazzarino G., and Giardina B. Malondialdehyde is a biochemical marker of peroxidative damage in the isolated reperfused rat heart. Mol Cell Biochem 116 (1992) 193-196
22. Ihnken K., Morita K., Buckberg G.D., Sherman M.P., Ignarro L.J., and Young H.H. Studies of hypoxemic/reoxygenation injury: with aortic clamping. J Thorac Cardiovasc Surg 110 (1995) 1274-1286
23. Ambrosio G., Weisfeldt M.L., Jacobus W.E., and Flaherty J.T. Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinant human superoxide dismutase administered at the time of reflow. Circulation 75 (1987) 282-291
24. Morita K., Ihnken K., and Buckberg G.D. Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts. J Clin Invest 93 (1994) 2658-2666
25. Littauer A., and DeGroot H. Release of reactive oxygen by hepatocytes on reoxygenation: three phases and role of mitochondria. Am J Physiol 262 (1992) G1015-G1020
26. Laine G.A., and Allen S.J. Left ventricular myocardial edema: lymph flow, interstitial fibrosis, and cardiac function. Circ Res 68 (1991) 1713-1721
27. Garcia-Dorado D., and Oliveras J. Myocardial edema: a preventable cause of reperfusion injury?. Cardiovasc Res 27 (1993) 1555-1563
28. Mehlhorn U., Allen S.J., Adams D.L., Davis K.L., Gogola G.R., de Vivie E.R., et al. Normothermic continuous antegrade blood cardioplegia does not prevent myocardial edema and cardiac dysfunction. Circulation 92 (1995) 1940-1946
29. Schaper J., Mulch J., Winkler B., and Schaper W. Ultrastructural, functional, and biochemical criteria for estimation of reversibility of ischemic injury: a study on the effects of global ischemia on the isolated dog heart. J Mol Cell Cardiol 11 (1979) 521-541